What we are studying
The purpose of this study is to see if localized chemotherapy to the liver (chemoembolization) combined with sorafenib will help patients live longer than treatment with chemoembolization alone.
Sorafenib or placebo will be provided by the study. No other compensation will be provided.
If contacting the study coordinator about this trial, please refer to study #CTSU E1208.